New Plans to Increase Sekur's Marketshare and Sales Globally - Targeting VIPs, C-Level Execs and Governments VANCOUVER, BC / ACCESS Newswire / August 26, 2025 / Sekur Private Data Ltd. (OTCQB:SWISF)(C
TARPON SPRINGS, Fla., August 26, 2025 -- Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing steno
Biohaven's troriluzole shows 50%-70% slowing of SCA disease progression, with FDA review now on track for Q4 2025 after a brief delay. FDA is no longer requiring an advisory committee meeting to revie
Viking's oral VK2735 efficacy was strong, but tolerability issues and high discontinuation rates cloud its competitive edge in the obesity drug market. The market's perception of Viking shifted after
Celldex Therapeutics, Inc.'s barzolvolimab failed to improve symptoms in eosinophilic esophagitis, but this setback doesn't impact its promising ongoing urticaria programs. Phase 3 trials for chronic
Energy Fuels is planning to install large-scale dysprosium, terbium, and potentially other "heavy" rare earth oxide production capacity at its White Mesa Mill in Utah by Q4-2026. DENVER , Aug. 21, 202
Projected to Contribute $40 Million in Annual Sales to Hyperscale Data LAS VEGAS , Aug. 21, 2025 /PRNewswire/ -- Hyperscale Data, Inc. (NYSE American: GPUS), a diversified holding company ("Hyperscal
We reiterate our Buy rating for K92 Mining, driven by strong production growth, robust financials, and ongoing expansion at the Kainantu mine. K92's Q2 2025 results were staggering: revenue up 102%, n
Trump's executive order streamlining space regulations could accelerate Lockheed's Orion, ULA launches and broader space ambitions.
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation for ADX-2191

Viking Therapeutics: Still On Track

08:56pm, Monday, 18'th Aug 2025
Viking Therapeutics offers a speculative opportunity, driven by its promising obesity drug pipeline and the massive potential of the GLP-1 market. Early clinical data for VK2735 is competitive, even o
Energi to acquire 51% of Tembo with VivoPower continuing to hold a significant shareholding in Tembo post-SPAC merger Energi is supportive of Tembo's business combination with Cactus Acquisition Corp
Eldorado Gold posted strong Q2 2025 results, with gold production and revenue surpassing expectations, but persistent cost inflation remains a key concern. Operational costs rose sharply year-over-yea
Five years ago, who would've guessed that O'Reilly Automotive (ORLY 0.04%) would be one of the market's big winners? But its share price is up roughly 240% since then on a split-adjusted basis, crush
Microchip Technologies NASDAQ: MCHP continues to face headwinds, including end-market inventory normalization, but the darkest days are behind it. The Q1 results and guidance outlook affirm what the Q
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE